<?xml version="1.0" encoding="UTF-8"?>
<ref id="B34-viruses-12-00177">
 <label>34.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chang</surname>
    <given-names>C.H.</given-names>
   </name>
   <name>
    <surname>Gupta</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Michel</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Loo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Cardillo</surname>
    <given-names>T.M.</given-names>
   </name>
   <name>
    <surname>Goldenberg</surname>
    <given-names>D.M.</given-names>
   </name>
  </person-group>
  <article-title>Ranpirnase (frog RNase) targeted with a humanized, internalizing, anti-Trop-2 antibody has potent cytotoxicity against diverse epithelial cancer cells</article-title>
  <source>Mol. Cancer Ther.</source>
  <year>2010</year>
  <volume>9</volume>
  <fpage>2276</fpage>
  <lpage>2286</lpage>
  <pub-id pub-id-type="doi">10.1158/1535-7163.MCT-10-0338</pub-id>
  <?supplied-pmid 20663928?>
  <pub-id pub-id-type="pmid">20663928</pub-id>
 </element-citation>
</ref>
